SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Publikationen

Kuse ER. Organtransplantation. In: Buchardi, Larsen, Schuster, Suter, eds. <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

Die Intensivmedizin. Berlin Heidelberg New York: Springer-Verlag, 2004; 1113-1127.

 

Kuse ER, Caspari G. Infektionen bei Organ- und Gewebetransplantationen. In: Adam D, Doerr HW, Link H, Lode H eds.

Die Infektiologie. Berlin Heidelberg New York: Springer-Verlag, 2004, IV-36.1, 1316-1323

 

Jaeger K, Zenz S, Juttner B, Ruschulte H, Kuse E, Heine J, Piepenbrock S, Ganser A, Karthaus M.

Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.

Ann Hematol. 2004 Nov 10; [Epub ahead of print]

 

Juttner B, Kuse ER, Elsner HA, Heine J, Jaeger K, Piepenbrock S, Scheinichen D.

Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients.

Eur J Anaesthesiol. 2004 Apr;21(4):309-13.

 

Luck R, Boger J, Kuse E, Klempnauer J, Nashan B.

Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.

Liver Transpl. 2004 May;10(5):686-91.

 

Ruschulte H, Jaeger K, Kuse E. Anästhesie in der Viszeralchirurgie. In: Pichlmayr I, Jaeger K, eds. Kompendium der Anästhesiologie - Standards und Entwicklungen. Landsberg/Lech: Ecomed Medizin, 2003; IV-1.1.5, 1-14.

 

Niemeyer G, Koch M, Light S, Kuse ER, Nashan B.

Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients.

Am J Transplant. 2002 May;2(5):454-60.

 

Kuse ER, Kotzerke J, Muller S, Nashan B, Luck R, Jaeger K.

Hepatic reticuloendothelial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation - a double-blind study.

Transpl Int. 2002 Jun;15(6):272-7. Epub 2002 Apr 30.

 

Kuse E. Die Bedeutung des Gerinnungssystems in der schweren Sepsis - therapeutische Beeinflussung durch rekombinantes aktiviertes Protein C. Medizin im Dialog 2001; 4:I-VI.

 

Jaeger K, Gehrmann A, Juttner B, Heine J, Bartsch S, Przemeck M, Scheinichen D, Ruschulte H, Loss M, Kuse ER, Winkler M.

Leukocyte phagocytosis is impaired during kidney xenotransplantation.

Transplant Proc. 2001 Nov-Dec;33(7-8):3869-70. No abstract available.

 

Jaeger K, Heine J, Ruschulte H, Juttner B, Scheinichen D, Kuse ER, Piepenbrock S.

Effects of colloidal resuscitation fluids on the neutrophil respiratory burst.

Transfusion. 2001 Aug;41(8):1064-8.

 

Jaeger K, Ruschulte H, Heine J, Scheinichen D, Leuwer M, Winkler M, Kuse ER.

Neutrophil respiratory burst following liver transplantation: in vitro effects of granulocyte colony-stimulating factor.

Transpl Infect Dis. 1999 Sep;1(3):153-6.

 

Kuse ER, Jaeger K.

Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease.

Transpl Int. 2001;14(1):55. No abstract available.

 

Weimann A, Plauth M, Bischoff SC, Kuse ER.

Nutrition of liver transplant patients.

Can J Gastroenterol. 2000 Nov;14 Suppl D:85D-88D. Review.

 

Jaeger K, Scheinichen D, Heine J, Ruschulte H, Kleine HD, Kuse ER, Piepenbrock S.

[In Process Citation]

Arzneimittelforschung. 2000 Oct;50(10):941-5. German.

 

Marx G, Vangerow B, Burczyk C, Gratz KF, Maassen N, Cobas Meyer M, Leuwer M, Kuse E, Rueckholdt H.

Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients.

Intensive Care Med. 2000 Sep;26(9):1252-8.

 

Jaeger K, Ruschulte H, Heine J, Scheinichen D, Kuse ER.

Neutrophils respiratory burst is not impaired under cyclosporine treatment following liver transplantation.

Transplantation. 2000 Apr 27;69(8):1752-3. No abstract available.

 

Kuse ER, Langefeld I, Jaeger K, Kulpmann WR.

Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection.

Crit Care Med. 2000 Feb;28(2):555-9.

 

Jaeger K, Scheinichen D, Heine J, Ruschulte H, Kuse E, Winkler M, Leuwer M.

GM-CSF increases in vitro the respiratory burst of human neutrophils after liver transplantation.

Intensive Care Med. 1999 Jun;25(6):612-5.

 

Schult M, Lohmann D, Knitsch W, Kuse ER, Nashan B.

Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.

Transplantation. 1999 Jun 15;67(11):1497-8.

 

Oldhafer KJ, Lang H, Kuse ER, Martin MU.

High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome.

Am J Med. 1998 Oct;105(4):346-7. No abstract available.

 

Weimann A, Kuse ER, Bechstein WO, Neuberger JM, Plauth M, Pichlmayr R.

Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant units.

Transpl Int. 1998;11 Suppl 1:S289-91.

 

Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R.

Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?

Clin Transplant. 1998 Jun;12(3):206-11.

 

Vogel U, Luneberg E, Kuse ER, Neulinger AL, Frosch M.

Extragenital Mycoplasma hominis infection in two liver transplant recipients.

Clin Infect Dis. 1997 Mar;24(3):512-3. No abstract available.

 

Kuse ER, Meyer M, Constantin R, Oldhafer K, Schlitt HJ, Schulz-Knappe P, Uberbacher HJ, Pichlmayr R, Forssmann WG.

[Urodilatin (<?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation]

Anaesthesist. 1996 Apr;45(4):351-8. German.

 

Liebau P, Kuse E, Winkler M, Schlitt HJ, Oldhafer K, Verhagen W, Flik J, Pichlmayr R.

Management of herpes simplex virus type 1 pneumonia following liver transplantation.

Infection. 1996 Mar-Apr;24(2):130-5.

 

Nashan B, Schlitt HJ, Schwinzer R, Ringe B, Kuse E, Tusch G, Wonigeit K, Pichlmayr R.

Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients.

Transplantation. 1996 Feb 27;61(4):546-54.

 

Schlitt HJ, Tischler HJ, Ringe B, Raddatz G, Maschek H, Dietrich H, Kuse E, Pichlmayr R, Link H.

Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.

Bone Marrow Transplant. 1995 Sep;16(3):473-8.

 

Kiuchi T, Kuse ER, Oldhafer KJ, Ringe B, Okamoto S, Bornscheuer A, Brabant G, Yamaoka Y, Pichlmayr R.

Implications of host pancreatic hormones in the restart of grafted liver.

Hepatology. 1995 Jun;21(6):1561-7.

 

Meyer M, Schulz-Knappe P, Kuse ER, Hummel M, Hetzer R, Pichlmayr R, Forssmann WG.

[Urodilatin. Use of a new peptide in intensive care]

Anaesthesist. 1995 Feb;44(2):81-91. Review. German.

 

Cedidi C, Meyer M, Kuse ER, Schulz-Knappe P, Ringe B, Frei U, Pichlmayr R, Forssmann WG.

Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation.

Eur J Clin Invest. 1994 Sep;24(9):632-9.

 

Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R.

Total hepatectomy and liver transplantation as two-stage procedure.

Ann Surg. 1993 Jul;218(1):3-9.

 

Cedidi C, Kuse ER, Meyer M, Oldhafer K, Ringe B, Wahlers T, Cremer J, Frei U, Pichlmayr R, Forssmann WG.

Treatment of acute postoperative renal failure after liver and heart transplantation by urodilatin.

Clin Investig. 1993 Jun;71(6):435-6. No abstract available.

 

Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R.

Management of emergencies before and after liver transplantation by early total hepatectomy.

Transplant Proc. 1993 Feb;25(1 Pt 2):1090. No abstract available.

 

Schlitt HJ, Ringe B, Rodeck B, Burdelski M, Kuse E, Pichlmayr R.

Bone marrow dysfunction after liver transplantation for fulminant non-A, non-B hepatitis. High risk for young patients.

Transplantation. 1992 Nov;54(5):936-7. No abstract available.

 

Ringden O, Meunier F, Tollemar J, Ricci P, Tura S, Kuse E, Viviani MA, Gorin NC, Klastersky J, Fenaux P, et al.

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.

J Antimicrob Chemother. 1991 Oct;28 Suppl B:73-82.

 

Ringe B, Pichlmayr R, Ziegler H, Grosse H, Kuse E, Oldhafer K, Bornscheuer A, Gubernatis G.

Management of severe hepatic trauma by two-stage total hepatectomy and subsequent liver transplantation.

Surgery. 1991 Jun;109(6):792-5.

 

Kuse ER, Wassmann RM, Ringe B, Bunzendahl H, Lehmkuhl P, Pichlmayr I, Pichlmayr R.

[Fatty emulsions in parenteral feeding following liver transplantation. A study of the neurotropic effect of MCT/LCT emulsions using EEG]

Anasthesiol Intensivmed Notfallmed Schmerzther. 1991 Apr;26(2):96-101. German.

 

Fritz KW, Ringe B, Hauss J, Kuse E, Seitz W.

[A review of the present status of liver transplantation]

Anaesthesiol Reanim. 1991;16(6):347-56. Review. German.

 

Kuse ER, Kotzerke J, Ringe B, Wassmann R, Gubernatis G, Pichlmayr I.

[Fat emulsions in parenteral feeding following liver transplantation. I. Effect on the recovery of RES function in the transplant]

Anasth Intensivther Notfallmed. 1990 Dec;25(6):428-31. German.

 

Osaki N, Ringe B, Bunzendahl H, Taki Y, Gubernatis G, Oellerich M, Kuse ER, Burdelski M, Uemoto S, Kimoto M, et al.

Postoperative recovery of mitochondrial function of the human liver graft procured and preserved with University of Wisconsin (UW) solution.

Transpl Int. 1990 Oct;3(3):128-32.

 

Kuse E, Vogt P, Rosenkranz B.

Pharmacokinetics of cefotaxime in patients after liver transplantation.

Infection. 1990 Sep-Oct;18(5):268-72.

 

Gubernatis G, Kemnitz J, Bornscheuer A, Kuse ER, Pichlmayr R.

Potential various appearances of hyperacute rejection in human liver transplantation.

Langenbecks Arch Chir. 1989;374(4):240-4.

 

Pichlmayr R, Gubernatis G, Grosse H, Seitz W, Mauz S, Ennker I, Mei M, Klempnauer J, Hauss J, Kuse ER.

[Liver transplantation in low portal vein flow: separation of portal vein areas with divided portal-venous and arterialized caval-venous liver perfusion. 1. Clinical case report]

Langenbecks Arch Chir. 1989;374(4):232-9. German.

 

Ringe B, Pichlmayr R, Lubbe N, Bornscheuer A, Kuse E.

Total hepatectomy as temporary approach to acute hepatic or primary graft failure.

Transplant Proc. 1988 Feb;20(1 Suppl 1):552-7. No abstract available.

 

Steinhoff G, Wonigeit K, Lauchart W, Ringe B, Kuse E, Pichlmayr R.

[Changes in MHC expression after orthoptic liver transplantation]

Beitr Infusionther Klin Ernahr. 1987;18:332-4. German. No abstract available.